Sequence-based prediction of pathological mutations

Proteins
Carles Ferrer-CostaXavier de la Cruz

Abstract

The development of methods to assess the impact of amino acid mutations on human health has become an important goal in biomedical research, due to the growing number of nonsynonymous SNPs identified. Within this context, computational methods constitute a valuable tool, because they can easily process large amounts of mutations and give useful, almost cost-free, information on their pathological character. In this paper we present a computational approach to the prediction of disease-associated amino acid mutations, using only sequence-based information (amino acid properties, evolutionary information, secondary structure and accessibility predictions, and database annotations) and neural networks, as a model building tool. Mutations are predicted to be either pathological or neutral. Our results show that the method has a good overall success rate, 83%, that can reach 95% when trained for specific proteins. The methodology is fast and flexible enough to provide good estimates of the pathological character of large sets of nonsynonymous SNPs, but can also be easily adapted to give more precise predictions for proteins of special biomedical interest.

References

Mar 27, 1975·Nature·C Chothia
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S Henikoff, J G Henikoff
Aug 5, 1987·Journal of Molecular Biology·S MillerC Chothia
Jul 1, 1995·Nature Structural Biology·M B SwindellsJ M Thornton
Jul 20, 1993·Journal of Molecular Biology·B Rost, C Sander
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Sep 25, 1997·Trends in Biochemical Sciences·H C PaceM Lewis
May 25, 1999·Protein Science : a Publication of the Protein Society·A J ShepherdJ M Thornton
Sep 2, 1999·Trends in Biochemical Sciences·N GuexM C Peitsch
Dec 11, 1999·Nucleic Acids Research·A Bairoch, R Apweiler
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Apr 27, 2000·Trends in Genetics : TIG·S SunyaevP Bork
Jun 1, 2000·Advances in Protein Chemistry·S SunyaevJ Reich
Mar 7, 2001·Human Molecular Genetics·S SunyaevP Bork
Mar 10, 2001·Nature·A Chakravarti
Apr 11, 2001·Human Mutation·Z Wang, J Moult
May 5, 2001·Genome Research·P C Ng, S Henikoff
Oct 24, 2001·Human Molecular Genetics·L Goodstadt, C P Ponting
Dec 26, 2001·Nucleic Acids Research·Alex BatemanErik L L Sonnhammer
Jan 17, 2002·Human Mutation·Andrew C R MartinJanet M Thornton
Jan 29, 2002·Journal of Molecular Biology·Carles Ferrer-CostaXavier de la Cruz
Mar 5, 2002·Genome Research·Pauline C Ng, Steven Henikoff
Jul 16, 2002·Bioinformatics·Manuel C Peitsch
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Aug 31, 2002·Nucleic Acids Research·Vasily RamenskyShamil Sunyaev
Sep 7, 2002·Journal of Molecular Biology·Richard BonneauDavid Baker
Sep 25, 2002·Journal of Molecular Biology·Christopher T Saunders, David Baker
Jun 20, 2003·Human Mutation·M F Santibáñez KorefJ M Hancock
Sep 6, 2003·Trends in Genetics : TIG·Robert E StewardJanet M Thornton
Dec 4, 2003·Annals of Human Genetics·M P MillerS Kumar

❮ Previous
Next ❯

Citations

Feb 10, 2010·Archives of Neurology·Chang-En YuVivianna M Van Deerlin
Mar 29, 2008·Pathology Oncology Research : POR·Eniko KámoryOrsolya Csuka
Apr 2, 2011·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Natasha KraevaDavid H Maclennan
Jul 12, 2012·European Journal of Human Genetics : EJHG·Qiuying ShaShuanglin Zhang
Aug 19, 2011·Nature Reviews. Genetics·Gregory M Cooper, Jay Shendure
Dec 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Francois Gros-LouisJean-Pierre Julien
Dec 23, 2004·Bioinformatics·A Cavallo, A C R Martin
May 10, 2005·Bioinformatics·Carles Ferrer-CostaModesto Orozco
Jan 20, 2007·Bioinformatics·Matthew A CareDavid R Westhead
Jul 18, 2006·Nucleic Acids Research·Lucía CondeJoaquín Dopazo
May 29, 2007·Nucleic Acids Research·Yana Bromberg, Burkhard Rost
Dec 10, 2009·Pharmacogenetics and Genomics·James C Sacco, Lauren A Trepanier
Nov 21, 2008·Journal of the Royal Society, Interface·Gabrielle A ReevesJanet M Thornton
May 12, 2009·Molekuliarnaia biologiia·V E Ramenskiĭ, Sh R Siuniaev
Jul 11, 2006·Annual Review of Genomics and Human Genetics·Pauline C Ng, Steven Henikoff
Jan 21, 2012·Human Heredity·Margarida C LopesEleftheria Zeggini
Oct 26, 2011·BMC Bioinformatics·Jose M G IzarzugazaAlfonso Valencia
Dec 7, 2013·BMC Bioinformatics·Hanka VenselaarGert Vriend
Jul 21, 2007·BMC Bioinformatics·David TalaveraXavier de la Cruz
Nov 13, 2010·PloS One·Thomas J HoffmannJohn S Witte
Mar 27, 2012·PloS One·Mohammed Akli AyoubLuba Kalaydjieva
Dec 19, 2013·Hereditary Cancer in Clinical Practice·Mev Dominguez-ValentinBenedito M Rossi
Dec 24, 2013·Anesthesia and Analgesia·Anja H SchiemannKathryn M Stowell
Apr 21, 2009·Pharmacogenomics·Grace S Y PangCaroline G L Lee
Apr 25, 2012·Journal of Molecular Neuroscience : MN·Manuela Barbosa Rodrigues de Souza, João Ricardo Mendes de Oliveira
Aug 29, 2014·Journal of the Royal Society, Interface·Tobias Sikosek, Hue Sun Chan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.